1. Promising Newer Molecular-Targeted Therapies in Head and Neck Cancer

   • Lili X. Wang
   • Mark Agulnik

   Leading Article 12 September 2012 Pages: 1609 - 1619

   

2. Managing the Patient with Co-Morbid Depression and an Anxiety Disorder

   • Robert A. Schoevers
   • Henricus L. Van
   • Jack J. Dekker

   Therapy in Practice 12 September 2012 Pages: 1621 - 1634

   

3. Endothelin Receptor Antagonism

   • Peter Kabunga
   • Gerry Coghlan

   Review Article 12 September 2012 Pages: 1635 - 1645

   

4. Platelet Activation, and Antiplatelet Targets and Agents

   • Yao-Zu Xiang
   • Ye Xia
   • Bo-Li Zhang

   Review Article 12 September 2012 Pages: 1647 - 1664

   

5. An Evaluation of Eptacog Alfa in Nonhaemophiliac Conditions

   • Gordon Mallarkey
   • Tim Brighton
   • Madien Gazarian

   Review Article 12 September 2012 Pages: 1665 - 1689

   

6. Cevimeline

   • Juliane Weber
   • Gillian M. Keating

   Adis Drug Profile 12 September 2012 Pages: 1691 - 1698

   

7. Dabigatran Etexilate

   • Mark Sanford
   • Greg L. Plosker

   Adis Drug Profile 12 September 2012 Pages: 1699 - 1709

   

8. Fentanyl Transdermal Matrix Patch (Durotep® MT Patch; Durogesic® DTrans®; Durogesic® SMAT)

   • Sheridan M. Hoy
   • Gillian M. Keating

   Adis Drug Profile 12 September 2012 Pages: 1711 - 1721

   

9. Mometasone Furoate

   • Claudine M. Baldwin
   • Lesley J. Scott

   Adis Drug Evaluation 12 September 2012 Pages: 1723 - 1739

   

10. Ciclesonide

    • Emma D. Deeks
    • Caroline M. Perry

    Adis Drug Evaluation 12 September 2012 Pages: 1741 - 1770